CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

Core Viewpoint - CG Oncology, Inc. is preparing to present at the 44th Annual J.P. Morgan Healthcare Conference, highlighting its focus on developing a bladder-sparing therapeutic for bladder cancer patients [1]. Company Overview - CG Oncology is a late-stage clinical biopharmaceutical company dedicated to developing and commercializing innovative immunotherapies aimed at improving the quality of life for patients with bladder cancer [3]. - The company envisions a future where urologic cancer patients can benefit from its therapies, allowing them to live with dignity [3]. Event Details - Arthur Kuan, Chairman & CEO, and Ambaw Bellete, President & COO, will present at the conference on January 15, 2026, at 8:15 am PT / 11:15 am ET [1]. - The conference will be held at the Westin St. Francis in San Francisco, California [1]. - Interested parties can access a live audio webcast of the presentation from the company's Investor Relations section on its website, with a replay available for approximately 90 days post-event [2].